Comparisons · Insurance & Coverage

Noom Med Prior Authorization Help for GLP-1: What to Expect

Written by the Luma Health Medical Team. Medically reviewed by Christina Bertoni, APRN.

Editorial disclosure: Luma Health is a GLP-1 telehealth provider and competes with Noom Med for the same patients. We've tried to describe Noom Med's prior authorization process accurately, including where it genuinely works well, before making the case for a flat-rate alternative.

Noom Med runs two separate tracks, and which one you land on changes your prior authorization experience completely. If you're on the branded-medication track (Wegovy, Zepbound, Ozempic, Mounjaro), your prescription cost depends on insurance approval, and that approval process has a real, documented timeline: prior authorization requests commonly take up to two weeks to process, and if denied, an appeal can take up to 90 days to resolve. If you're on Noom's compounded GLP-1Rx track instead, insurance isn't part of the equation at all, you pay a fixed monthly price whether or not you have coverage. Knowing which track you're actually on, and what that means for your timeline, is the first thing to sort out before anything else.

What this page covers

How Noom Med's prior authorization process actually works and how long it typically takes, the difference between Noom's branded and compounded tracks, what to do if you're denied, and how Luma Health's flat pricing compares once you factor in the real cost of waiting.

Noom Med's Two Tracks, and Why They Matter for Prior Authorization

Noom Med for branded medications is built around insurance: the membership itself runs roughly $39 to $69 to start and about $99/month afterward, but that fee doesn't include the medication. If your clinician prescribes a branded GLP-1 like Wegovy or Zepbound, Noom's team submits a prior authorization request to your insurer on your behalf, then you wait for a decision. Reported timelines for this process commonly run up to two weeks for an initial decision, and if the request is denied, an appeal process can take up to an additional 90 days to resolve.

Noom's separate GLP-1Rx track (including its Microdose and Plus tiers) works differently: compounded semaglutide is included directly in a flat monthly price, generally in the $99 to $299/month range depending on tier, with no insurance billing and no prior authorization step at all. The tradeoff is the same one that runs through this entire category: insurance-dependent pricing can be cheaper if it's approved, but it comes with real timeline risk; flat-rate compounded pricing is more expensive on paper for some patients but removes the waiting entirely.

The Prior Authorization Timeline, in Numbers

Up to 2 weeks typical wait for an initial prior authorization decision on a branded GLP-1

Up to 90 days typical appeal timeline if the initial request is denied

19% → 43% share of employers (200+ vs. 5,000+ workers) covering GLP-1s for weight loss in 2025, per KFF

Put together, a worst-case scenario, denial followed by a full appeal, can mean roughly three months between your first telehealth visit and an actual coverage decision. That's not a criticism of Noom specifically; it reflects how prior authorization and appeals work across the industry for any provider billing GLP-1s through insurance. The real question is whether your specific plan is likely to approve quickly, deny outright, or land somewhere in between, and that's worth finding out before you commit to the branded track.

Coverage by Plan Type: Setting Realistic Expectations

Plan type	Typical GLP-1 weight-loss coverage	What slows down approval
Large employer (5,000+ employees)	More common (~43% in 2025)	Still often requires documented BMI/comorbidity and step therapy
Small/mid employer (200+ employees)	Less common (~19%)	Category exclusions mean no PA can succeed regardless of documentation
ACA Marketplace plans	Rare for obesity-specific brands	Formulary tier restrictions and diabetes-only coverage
Medicare Part D	Not covered for weight loss by law	Any weight-loss-coded PA request is denied by statute, not process
Medicaid	State-optional; varies widely	State-specific formulary and eligibility rules

What to Do While You Wait

If you're early in the PA process

Ask Noom's team what documentation was submitted and whether your specific plan requires step therapy
Call your insurer directly to confirm the request was received and ask for an expected decision date
Ask about expedited review if a treatment gap poses a clinical concern
Consider Noom's own compounded GLP-1Rx track as a bridge if the branded wait becomes untenable

If you've already been denied

Get the denial reason in writing before deciding whether to appeal
A 90-day appeal timeline means roughly a full quarter without your intended medication if you wait it out
Weigh a flat-rate compounded option against the cost of waiting, especially if your plan excludes the category outright
If you switch, ask your new prescriber about dose-continuity to avoid restarting titration from scratch

Deciding Whether to Wait or Switch: 5 Steps

Confirm which Noom Med track you're actually on. Branded-medication PA timelines don't apply if you're already on the compounded GLP-1Rx track, so check your plan details before assuming a delay is coming.

Call your insurer and ask if weight-loss GLP-1s are excluded at the plan level. If they are, no amount of waiting through PA will change the outcome, and switching tracks or providers is the faster path.

If your plan does cover the category, ask for a specific timeline estimate and put a personal deadline on it, since two weeks can quietly become two months without a checkpoint.

Price out a flat-rate compounded option in parallel so you have a fallback ready the moment your deadline passes, rather than starting that research from zero after a denial.

If you do switch, bring your current dose and titration history to your new prescriber so you don't lose progress by restarting at the lowest dose.

Noom Med vs. Luma Health: Where Each Fits

Noom Med's branded track may fit you if:

Your employer plan is among the roughly 43% of large employers covering GLP-1s for weight loss
You want Noom's behavioral coaching and app-based habit tools alongside medication
You can tolerate a multi-week wait, or longer if appeal is needed
You want help navigating prior authorization paperwork rather than doing it yourself

Luma Health may fit better if:

You don't have GLP-1 coverage, or your plan excludes the category entirely
You've already been denied once and don't want to spend a quarter waiting on an appeal
You want a flat, predictable monthly price with no prior authorization step
You want to start treatment now rather than after a coverage decision

Luma Health's compounded semaglutide and tirzepatide are priced flat at $197/month and $297/month, with no insurance billing and therefore no prior authorization to wait on. Compared against Noom Med's own compounded GLP-1Rx tiers, which range roughly $99 to $299/month depending on plan, pricing is broadly comparable at the top end and Noom can be less expensive at its lower Microdose tier; the meaningful difference between the two isn't price so much as dosing structure and program design, so compare the specific tier and dose you'd actually be prescribed before deciding.

What the Clinical Evidence Supports

Prior authorization timelines are an insurance-process question, separate from the underlying clinical evidence. Semaglutide's weight-loss efficacy comes from the STEP program, including STEP 1 (NEJM 2021), with cardiovascular outcome data in SELECT (NEJM 2023). Tirzepatide's data comes from the SURMOUNT program, including SURMOUNT-1 (NEJM 2022), with head-to-head comparison data against semaglutide in SURPASS-2 (NEJM 2021). None of this evidence changes based on whether your specific claim is approved, denied, or never billed to insurance at all.

Frequently Asked Questions

How long does Noom Med's prior authorization process actually take?

For branded medications like Wegovy or Zepbound, initial prior authorization decisions commonly take up to two weeks. If the request is denied and you choose to appeal, that process can take up to an additional 90 days, meaning a worst-case timeline of roughly three months from your first visit to a final coverage decision.

Does Noom Med's compounded GLP-1Rx program require prior authorization?

No. Noom's compounded track, including the Microdose and Plus tiers, is priced as a flat monthly fee that includes the medication, so there's no insurance billing and no prior authorization step involved. This is a meaningfully different experience than the branded-medication track.

What happens if my Noom Med prior authorization is denied?

You can appeal, which typically takes up to 90 days to resolve, or switch to a cash-pay option, either Noom's own compounded track or a flat-rate provider like Luma Health, while you decide whether the appeal is worth pursuing. Get your denial reason in writing first, since a hard plan-level exclusion is very unlikely to be overturned on appeal.

Is it faster to just pay cash instead of going through prior authorization?

Usually, yes, in terms of time to start treatment. Cash-pay options skip the prior authorization and appeal timeline entirely. Whether it's cheaper overall depends on your specific insurance benefits; if your plan would have approved a low-copay branded medication quickly, waiting may cost less in total than paying cash from day one.

Can I switch between Noom Med's branded and compounded tracks?

Noom Med offers both as separate program tiers, so check with their team directly about switching between them, particularly if you started on the branded track and want to move to compounded medication while a prior authorization is pending.

Does Luma Health require prior authorization for semaglutide or tirzepatide?

No. Luma Health's compounded medications are priced flat at $197/month for semaglutide and $297/month for tirzepatide, billed directly to you rather than through insurance, so there's no prior authorization process, formulary check, or approval wait involved.

Is Luma Health cheaper than Noom Med?

It depends on which Noom Med tier and dose you'd be prescribed. Against Noom's compounded GLP-1Rx tiers ($99–$299/month), pricing is broadly comparable, with Noom's Microdose option potentially less expensive and its higher tiers roughly in line with Luma Health's flat rates. Against Noom's branded track, the comparison depends entirely on your insurance approval and copay, which Luma Health's flat pricing avoids having to predict.

Sources & References

Medical disclaimer: This content was researched and reviewed by the Luma Health medical team for general educational purposes only and does not constitute medical, legal, or insurance advice. Prior authorization timelines, appeal windows, and coverage terms vary by plan, employer, and insurer, and change frequently; verify your specific plan's current terms directly with your insurer and with Noom Med before making treatment decisions. Compounded semaglutide and tirzepatide are prepared per individual prescription and are not themselves FDA-approved drug products; the active ingredients are FDA-approved in corresponding brand formulations. Luma Health's clinical services are provided by Wasef Health, PC, with medication dispensed by VialsRX, a 503A pharmacy licensed by the Texas State Board of Pharmacy (License #35264), verifiable at pharmacy.texas.gov. Always consult a licensed healthcare provider before starting, stopping, or changing any weight-loss treatment.